Department of Chemical Engineering, The Pennsylvania State University, University Park, PA, 16802, USA.
Pfizer Inc., 1 Burtt Rd, Andover, MA, 01810, USA.
Pharm Res. 2021 Jan;38(1):155-163. doi: 10.1007/s11095-020-02983-w. Epub 2021 Jan 12.
Sterile filtration can be a particular challenge when processing very large glycoconjugate vaccines. The objective of this study was to examine the sterile filtration performance of a series of glycoconjugate vaccines produced by coupling different polysaccharide serotypes to an immunogenic protein.
Sterile filtration was performed at constant filtrate flux using 0.22 μm pore size Durapore® polyvinylidene fluoride membranes. Glycoconjugates were characterized by dynamic light scattering, rheological measurements, and nanoparticle tracking analysis (NTA). Confocal microscopy was used to examine glycoconjugate capture profiles within the membrane. Transmembrane pressure data were analyzed using a recently developed fouling model.
All glycoconjugates deposited in a narrow band near the entrance of the Durapore® membranes. The rate of fouling varied significantly for the different serotypes, with the fouling parameter correlated with the fraction of glycoconjugates larger than 200 nm in size.
The fouling behavior and sterile filter capacity of the different glycoconjugate serotypes are determined primarily by the presence of large species (>200 nm in size) as determined by nanoparticle tracking analysis. The modified intermediate pore blockage model provides a framework for predicting the sterile filtration performance for these glycoconjugate vaccines.
在处理非常大的糖缀合物疫苗时,无菌过滤可能是一个特别的挑战。本研究的目的是研究通过将不同多糖血清型与免疫原性蛋白偶联而产生的一系列糖缀合物疫苗的无菌过滤性能。
使用 0.22 μm 孔径的 Durapore®聚偏二氟乙烯膜,在恒定滤液通量下进行无菌过滤。通过动态光散射、流变测量和纳米颗粒跟踪分析(NTA)对糖缀合物进行表征。共焦显微镜用于检查膜内糖缀合物的捕获分布。使用最近开发的污垢模型分析跨膜压力数据。
所有糖缀合物都沉积在 Durapore®膜入口附近的一个狭窄带内。不同血清型的污垢速率差异很大,污垢参数与大于 200nm 大小的糖缀合物分数相关。
不同糖缀合血清型的污垢行为和无菌过滤能力主要由纳米颗粒跟踪分析确定的大颗粒(大于 200nm 大小)的存在决定。改进的中间孔阻塞模型为这些糖缀合物疫苗的无菌过滤性能提供了预测框架。